People and Business News — 3/22
People News
Seqster PDM, Inc. announced the appointment of Bruno Villetelle, to its strategic advisory board.
Curebase has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.
NNIT has appointed Camilla G. Møhl as its new SVP and Chief People, Communications and Marketing Officer.
ClinOne has named Andrea Valente as Chief Executive Officer.
Advanced Clinical announced that Dr. Andreas Amrein has joined the Executive Team as Senior Vice President of Asia-Pacific and Japan, as well as Managing Director for Europe and Canada.
MMS Holdings announced this week the addition of Dr. Robert Allen as Principal Medical Director to its Global Drug Safety and Pharmacovigilance team.
Total Diversity Clinical Trial Management announced Mark Hanley as a Board Member and Advisor.
Business News
Florence Healthcare announced that 285 million Americans now live within 25-miles of a Florence digital-workflow-equipped clinical research site.
Calyx announced its electronic data capture system has been selected by a leading pharmaceutical company to capture Real World Evidence data for a global, late-phase study.
Rho announced that it has been named the Autoimmune Diseases Statistical and Clinical Coordinating Center for the National Institute of Allergy and Infectious Diseases.
Suvoda LLC launched a refreshed brand, to better reflect its leadership position as a global clinical trial technology company that specializes in highly complex studies, such as oncology, central nervous system, and rare disease.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
